international symposium on endovascular therapy (iset)

28
ISET Course Directors: Barry T. Katzen, M.D. James F. Benenati, M.D. Alex Powell, M.D. Shaun Samuels, M.D. Ramon Quesada, M.D. Constantino Peña, M.D. Adam Geronemus, M.D. Jane Kiah, RN, MS Italo Linfante, M.D. Guilherme Dadus, M.D. CIO 2013 The Fastest Growing Interventional Oncology Symposia in North America January 18-19 Miami Beach, FL In Collaboration with iset.org/oncology JANUARY 19-23, 2013 Guest Co-directors: Michael Jaff, D.O. Boston, Massachusetts Juan Granada, M.D. Orangeburg, New York Claudio Schonholz, M.D. Charleston, South Carolina Baptist Cardiac & Vascular Institute

Upload: mdconferencefindercom

Post on 05-Dec-2014

664 views

Category:

Documents


7 download

DESCRIPTION

 

TRANSCRIPT

Page 1: International Symposium on Endovascular Therapy (ISET)

ISET Course Directors: Barry T. Katzen, M.D. James F. Benenati, M.D.Alex Powell, M.D. Shaun Samuels, M.D. Ramon Quesada, M.D.

Constantino Peña, M.D.Adam Geronemus, M.D.Jane Kiah, RN, MSItalo Linfante, M.D.Guilherme Dadus, M.D.

CIO 2013 The Fastest Growing Interventional Oncology Symposia in North America

January 18-19 � Miami Beach, FL

In Collaboration with

iset.org/oncology

JANUARY 19-23, 2013

Guest Co-directors: Michael Jaff, D.O.Boston, Massachusetts

Juan Granada, M.D.Orangeburg, New York

Claudio Schonholz, M.D.Charleston, South Carolina

Baptist Cardiac & Vascular Institute

Page 2: International Symposium on Endovascular Therapy (ISET)

GREAT MOMENTS IN 1988 HISTORY. 25 YEARS AGO:� The Human Genome Organization is founded� Stephen Hawking’s “A Brief History in Time” is published���������������� ������������� � ���������������������� The International Symposium on Endovascular Therapy is launched

�������������������������������������������������� ���������������� ������� ������������ISET is constantly pushing the edge of the envelope, raising the bar – the only constant at ISET is change.How, you ask? Here’s what’s new at the 25th Annual ISET Symposium:

����������������� ��������� �From two to three hours a day �More cases, more of each case – access to closure – than any other meeting������������ �Saturday to Wednesday �Five full days – expanded by half a day over last year �Saturday and Sunday – hot topic focused symposia on stroke, venous interventions and embolotherapy�������������������������� �ISET Meets the AMERICAS �Stroke: Everything You Need to Know �Strategies for Success in the Changing Healthcare Economic Environment �Advances in Venous Intervention and Embolotherapy �Fundamentals of Vascular Diagnosis and Therapy: Practical Information on PAD Diagnosis and Management (endorsed by Society Interventional Radiology and Society of Vascular Medicine)����������� 39.25 hours

ISET WILL FEATURE SIMULTANEOUS TRANSLATION TO SPANISH AND PORTUGUESE.

������������������������!�"���#��Now Friday and Saturday��North America’s fastest-growing interventional oncology meeting��See separate pull-out brochure for full program details

Page 3: International Symposium on Endovascular Therapy (ISET)

$%� &�'�(' �(')�

SATURDAY

Your pick of one of three focused full-day sessions:

� ����*����)������+��%��.��%�/ �Comprehensive endovascular therapy summit for Latin American physicians �Simultaneous headset translation of each presentation in English, Spanish and Portuguese �The latest innovations and insights from Venezuela to Brazil, from emerging technologies in embolotherapy to marketing strategies to set up a successful clinical practice in Latin America

������)����������!�������/����)������+��%������� CALL FOR CASES Physicians attending the ISET Focused Symposium: ISET Meets the Americas are invited to submit a case for the opportunity to present their case orally. Multiple cases will be selected. The Call for Cases parameters are listed at www.ISET.org.

� ���*����4�/�����!+���&����������5�� �All about stroke, from health and economic aspects to etiologies �Stroke prevention, including medical management of asymptomatic carotid stenosis �Imaging and diagnosis �Update on clinical trials of endovascular stroke treatment

� 6+�%�������������������������7������������/�����%����������������8�������������)��+������� �Healthcare reform �Transformational transcatheter therapies �New interventional treatments for disease management �Quality and safety

Page 4: International Symposium on Endovascular Therapy (ISET)

$%� &�'�(' �(')�

SUNDAYYour pick of one of four focused full-day sessions:

�����!������������;��������7��������$������� �7.0 credits in non-invasive vascular diagnosis �Readers in ICAVL- accredited labs can gain a portion of required noninvasive CME to maintain privileges �Carotid Disease, from plaque morphology to interpreting carotid duplex exams �Arterial Disease – consensus panel on screening: carotids, lower extremity, AAA �Venous Disease, including controversies and exams

������������8�������������+���+�����'���+��������������������� �2nd Annual Vascular Masters Program: clinical and economic management �Optimizing reimbursement �������������������� !�������������� ����� � �����������"#$%

���%���������7������������������<���+����!� �Malformations – when and how to treat �Venous intervention – new techniques for recanalization ��'*������+�4���������6����������;<������ �CCSVI – techniques and treatment outcomes to date

��������������8�7��������$�����������)+����!/�����������8�������������%$�$������������������ �Opportunity to update your knowledge base and skills �Evaluation of patients with acute or critical limb ischemia �Carotid Disease – who gets treated and how? �AAA device selection �Acute DVT – anticoagulation vs. endovascular intervention

=>+�%�������!�?�������.���������+�������������4���"��<��������#�������8��@+�<��'���

Page 5: International Symposium on Endovascular Therapy (ISET)

$%� &�'�(' �(')�

MONDAY

����'�����$������������B�����������������/ �Renal intervention �Dialysis access intervention �Large vessel closure

���(������������/ �ISET Town Hall: Sympathetic Denervation – The Next Great Endovascular Breakthrough? �Does it have a role in sleep apnea and diabetes? �ISET Career Achievement Award: Gary J. Becker, MD – A pioneer in endovascular therapy, Dr. �= !���������� ������������������������������������ ����������� ����������� ������������������� radiology in a variety of roles. �Three hours of Live Cases! �Summit on Restenosis �*���������������!����������@�*X���6�<*��$�����������������@�������������������� ��������������������Z �Critical limb ischemia – crossing devices and stents for BTK intervention

������������������/ �Carotid stenting today �Abstracts and late-breaking trials �Hot topics in interventional cardiology, from atrial appendage closure to mitral valve repair

Don’t miss more in depth discussion of BTK lesions on Wednesday at 11am!

Page 6: International Symposium on Endovascular Therapy (ISET)

$%� &�'�(' �(')�

TUESDAY����'�����$������������B�case presentations in:�����[��*���������������!������[��*������������� ������������[��\���������������� ��

���(������������/�����[��]^�_������������ �������'<X

[���������������+�`������6������������6�]���^6����������;�� 6�\���������6�'����������[���������������j���*���{�����[��|�������������������'<X���������@������������� !��������������������[���������� � ������6�������������� ���� ����������_��_��_�������������

������������������/�����[��*������������� ����������������_������6�������������������

[��;���_ �������������@�����_��������6� �����������������_������������[����\�X���������@����������6�����_�������� ��������������� ������������� ������

�����[��� ��� ��� ������������'<X�������'<X[��|������������ �����������!�[��*����� �����������'<X6�� ���������������������

�����[��X����������� ���������������[��<����� ������������������ ������������[��X���������������������+������6���� !������ �������

�����[�������"#$%�\������������}_~�����[������� ������������������������������������������������������������� submitted from researchers around the world.

Page 7: International Symposium on Endovascular Therapy (ISET)

$%� &�'�(' �(')�

WEDNESDAY

����'�����$������������B�case presentations in:�����[����������<�� ������������[��;'���������������[������ ��������������������(������������/�����[��;���������������\<;+������������������������Z� [��;���_�������������������<������� [��*���������������6�|;�j ����@�<�������*������6�|;6���������!������*�����������*�� ���������������������� in the Management of Acute Iliofemoral DVT and Chronic Post-Thrombotic Iliofemoral Venous Obstruction. �������������[��*����������� ���� ��������� ����� [������������������'�<��<X��������������_��������<�������� [��*�������_������������������������_�������� �Z�����[�<���� �����_��_!�������������� [������������������+����������������������Z� [���^������������������������� ��������������������������������/����[������!�������� [��<��������������� �����������������!�������������� [�������������!������������������� ��������Z�����[��������� ���������*�`����_����� [���|<�� �����������+������������� !�� [��*����^��������������������� �����������[��;'�6�����������������������'*������� [�����������������������;'�������Z� [������� � �`������������+�������������6�������6��������Z

25 years of CME – and now, even more!

WEDNESDAYMORNING LIVE CASESISET/LINC –Transatlantic Live Cases and Lecture Session��[��\�������<���������=�������!���������

Fully interactive live cases back to back, bringing two worlds together

Featured Research and One case each from the LINC meeting (in Leipzig, Germany), and ISET in Miami

Page 8: International Symposium on Endovascular Therapy (ISET)

��������.�%)��� �������<F������

Upon completion of this activity, the physician should be able to:[� Apply evidence based medicine criteria to choose techniques and devices to treat cardiovascular disease.[� Incorporate medical management to improve patient outcomes of endovascular therapy.[� Utilize optimal noninvasive diagnostic techniques to diagnose, plan treatment for, and follow cardiovascular disease.[� ;�������� ��� ��������������� ����^� ������� ����� �������� ��������[� Utilize limb salvage techniques for patients with critical limb ischemia.[� Implement advanced techniques and treatment for complex aneurysms.[� <��������� ���������� ����������������������������� �������;'�6������6����������������� �����[� Implement principles and techniques for carotid revascularization procedures.[� Understand interventional techniques for treatment of severe hypertension.

)�����%������ ISET will be of value to interventional radiologists, vascular surgeons, interventional cardiologists, interventional neuroradiologists, cardiothoracic surgeons, clinical cardiologists, clinical radiologists, neurologists, internists and others involved in the treatment of cardiovascular disease.

%���������Complete Conference Management is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians.

������$�������Complete Conference Management designates this live activity for a maximum of 39.25 AMA PRA Category 1 CreditsTM. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

This includes 7.0 credits in Noninvasive Vascular Diagnosis.

�+��������� ������������������ ���� �����6�<��� ���]�����*�����������Center "ANCC) accepts AMA PRA Category 1 CreditTM from organizations accredited by the ACCME. American Academy of Nurse Practitioners (AANP) accepts AMA PRA Category 1 CreditTM from organizations accredited by the ACCME. American Academy of Physician Assistants (AAPA) accepts ���� ������������ �������������� ��������� �������� ����������AMA PRA Category 1 CreditTM from organizations accredited by the ACCME. Physician assistants may receive a maximum of %��"�����������*�������$� ��������� ���������������������� H���K�%���������������.������� The American Medical Association (AMA) has an agreement of mutual recognition of CME credit with the UEMS. Under the terms of this agreement the European Accreditation Council for Continuing Medical Education (EACCME), the accrediting arm of the UEMS, will convert CME credit for live activities �����������<|<�

������������������L�7������������/�%����������������8�������������)��+������� This activity has been submitted to Louisiana State Nurses Association for approval to award contact hours.

Louisiana State Nurses Association is accredited as an approver of continuing nursing education by the American Nurses Credentialing Center’s Commission on Accreditation.

For more information regarding contact hours, please call 4|<�*������*����� �|�����������%#�_"~�_""}%�The goal of this program is to provide an overview of the latest therapies and technologies in interventional cardiac and vascular services. Criteria for completion include registration and attendance at the entire nurse and technologist activity and completion of an online evaluation.Accreditation refers to educational content only and does not imply UMA/CCM, LSNA or ANCC endorsement of any product or service.

This program is in process of approval by the American Society of Radiological Technologists (ASRT) for Category A credits.

$����������The information provided at this CME activity is for continuing education purposes only and is not meant to substitute for the independent medical judgment of a physician relative ������������ ���������������������������� �� ����������medical condition.

�����!�$���������In accordance with ACCME® Accreditation requirements, �� ��������������������� ������������ �������������������relationship with the manufacturer(s) of any commercial product(s) and/or provider(s) of commercial services discussed during this educational activity and with any commercial supporters of this activity.

Continuing Medical Education

Page 9: International Symposium on Endovascular Therapy (ISET)

��7�)�$��%�H )&$���+!�%<��M�O�O��Silver Spring, Maryland

5����%<����M��P$PMiami, Florida

Q����%������M��P$PMiami, Florida

(��!�%���M��P$PColumbus, Ohio

�������%����M�.)".#M"�.#"�)#Miami, Florida

Q��+���O��4��M��P$PBoston, Massachusetts

�+������O����4M��+$Royal Oak, Michigan

������O���M��P$PBoston, Massachusetts

.�<���O����M��P$PSeattle, Washington

$�����O���4���M��P$PM�+$Heidelberg, Germany

���4�O��4�M��P$PToledo, Ohio

����������M��P$P�Boston, Massachusetts

�����������������M��P$PM��+$Sao Paulo, Brazil

$����������M��P$PCleveland, Ohio

%+�!��������M��P$PM.7)Toledo, Ohio

O��������Washington, D. C.

���+���������!M��P$PRichmond, Virginia

���4�������M��P$PBaltimore, Maryland

Q��4�������M��P$PLebanon, New Hampshire

Q���<��!���M��P$PBronx, New York

���+����$�4�M��P$PStanford, California

%���������������+�� �<��M��P$PSao Paulo, Brazil

�������������VM��P$PMiami, Florida

��������$��+�M��P$PBern, Switzerland

���������� ������Dallas, Texas

������������M��P$PMexico City, Mexico

��<��V���������M��P$PRome, Italy

)���������M��P$PEvanston, Illinois

)+�������������M��P$PMiami, Florida

$������M��P$PEnglewood, California

.�����(��+�M��P$PMiami, Florida

.�<����(����M��P$PRome, Italy

Q�8���(��V����M��P$PMinneapolis, Minnesota

�8����(�V���VM��P$PMiami, Florida

'��+���(���4M��P$PM�.7)Cleveland, Ohio

?�������(��!M��P$PNew York, New York

(�����(���M�%.��Miami, Florida

�<��+����(��<�M��P$PBonn, Germany

������(�������M��P$PTbd, Tbd

��������(�������M��P$P�Charleston, South Carolina

��+������'���M�.7)M�OO�+M�.�7�Miami, Florida

W���QP�'��4��M��P$PBaltimore, Maryland

P�������X���4Z�'��4��M��P$PBuffalo, New York

.��Q��4��San Francisco, California

��+���Q�+��M��P$P�Indianapolis, Indiana

)�����Q���M��P$PPittsburgh, Pennsylvania

?�������Q����M��P$PBoynton Beach, Florida

$�����5��V���M��P$PAtlanta, Georgia

Q�+�5��8��M��P$PPortland, Oregon

O����5����!Miami, Florida

������5������V4!M��P$PSao Paulo, Brazil

��������5�����M���$M�%.��Miami, Florida

���!�5����4��M�.)�".#"�7#Miami, Florida

W�������5��F���M��P$PHouston, Texas

5�+!�5���M��P$PIndianapolis, Indiana

������ �<��������M��P$PM��+$Stony Brook, New York

Q�+���� �����M��P$PVienna, Austria

����� ��M��P$PNew York, New York

Q��� ��<���!San Francisco, California

.�<��� ��4���M��P$PNew York, New York

���)���H.���$�.��)�.�/�Baptist Cardiac & Vascular Institute, Miami, Florida

O���!�)P�5�V�M��P$PMiami, Florida

Q������P�O����M��P$PMiami, Florida

%��@�������M��P$PMiami, Florida

�+����������M��P$PMiami, Florida

.����[������M��P$PMiami, Florida

���������\�M��P$PMiami, Florida

%����(�������M��P$PMiami, Florida

Q���5��+M�.�M���Miami, Florida

����� �8��M��P$PMiami, Florida

(���+�����$�<��M��P$PMiami, Florida

(H��)���;$�.��)�.�/ ���+����Q�88M�$P�PMassachusetts General Hospital, Boston, Massachusetts

Q���(�����M��P$POrangeburg, New York

����������+�+��VM��P$PCharleston, South Carolina

Page 10: International Symposium on Endovascular Therapy (ISET)

����!����+�M��P$PVancouver, British Columbia, Canada

(������]��VM�.)".#"�7#Miami, Florida

��������������Miami, Florida

5�������+���M��P$PDortmund, Germany

%����������M��P$PCharlottesville, Virginia

Q����������M��P$PMadison, Wisconsin

����������VM��P$PBuenos Aires, Argentina

���4��������M��P$PMilwaukee, Wisconsin

��F�!������M��P$PMinneapolis, Minnesota

��<���������M��P$PMiami, Florida

)���+!�����+!M��P$PProvidence, Rhode Island

���������������M��P$PPhiladelphia, Pennsylvania

.������������M��P$PAtlanta, Georgia

(������������+M��P$PRochester, Minnesota

���4���������M�.)".#Miami, Florida

Q�88��!����M�$�New York, New York

Q�+���<��M��P$PMinneapolis, Minnesota

����������������M��P$PPadua, Italy

Q����������VM��P$PSan Antonio, Texas

.�+�������M��P$PBaltimore, Maryland

Q�+���������M��P$PManhasset, New York

�+�������!M��P$PMiami, Florida

(��V�.��+��M��P$PM��+$Stuttgart, Germany

?�������.�����M��P$PMilwaukee, Wisconsin

���+����.�<<��M�.�M�O��Miami, Florida

%��.�<���M��P$PSan Diego, California

Q��+��.�<���M��P$PMiami, Florida

5���+��.��+�;���+M��P$P���������6���������

�������.��V���M��P$PCaracas, Venezuela

.�<���.���M��P$PNew York, New York

5��+�.���^���M��P$PBoston, Massachusetts

������.����M��P$PRome, Italy

Q�+�.��<��4M��P$PTeaneck, New Jersey

���+����.!���M��P$PMiami, Florida

.���+������M��P$PMiami, Florida

������������M��P$PM��+$Paris, France

.��+������@�M��P$PEncinitas, California

$���4���+����M��P$PLeipzig, Germany

��+����+���^M��P$PMesa, Arizona

%������+��M��O%Flagstaff , Arizona

(��!����4�M��P$PAlbany, New York

.�<���������M��P$PPeoria, Illinois

(��������M��P$PNew York, New York

.�<����)�������M�.)".#"�7#M"�)#Miami, Florida

(����)���M��P$PRosenheim, Germany

(������7��4��+���!M��P$PLos Angeles, California

$������7�V]��VM�.�Miami, Florida

���4�7��+M��P$PRiverdale, New York

%������.����M��P$PRio de Janeiro, Brazil

.��?�4���M��P$PWashington, District of Columbia

O���?���+��M��P$PGainesville, Florida

?�!��&�4��M��P$PEnglewood, Colorado

%�<���&��M��P$PBoston, Massachusetts

������W����M��P$PMilwaukee, Wisconsin

)+�����W�����M��P$PBad Krozingen, Germany

Q��4�W�88��M��P$PM��+$Miami, Florida

��7�)�$��%�H )&�"������#

Page 11: International Symposium on Endovascular Therapy (ISET)

Day 1: Saturday, January 19, 2013���)����������!���������/����)������+��%��.��%�

7:00 a.m. Breakfast

8:00 a.m. Session I: Advances in Aneurysm TherapyModerators:�O���!�5�V�M��P$PM�%������ �<��M��P$P

Welcome and IntroductionsCurrent Status of Aortic Aneurysm Treatment in Latin America %������.����M��P$PCone Beam CT and Fusion Imaging in Aneurysm Therapy ���������\�M��P$PSnorkles and Chimneys: Why and How? %������ �<��M��P$PBranched and Fenestrated Endografts: Which Patients and How Effective? (������������+M��P$PA Prospective Comparison Study Between Hypogastric Artery Endo-revascularization with "Sandwich Technique" Versus Coil Embolization in Complex Aortoiliac Aneurysms

%������ �<��M��P$P

Complex TAA: Innovative Solutions Are Needed, but at What Cost? ���4�������M��P$PManagement of Endoleaks ����������+�+��VM��P$PUnique Approaches to the Ascending Aorta O���!�5�V�M��P$PAdvances in Aortic Valve Therapy .����[������M��P$PTeam Building for Advanced Endovascular Procedures O���!�5�V�M��P$PLarge Vessel Closure for EVAR, TEVAR and TAVR W�������5��F���M��P$P

$#+##����� Refreshment Break $#+%#����� Session II: State-of-the-Art in Peripheral Arterial Disease

Arterial Disease in the Americas ������������M��P$PClinical and Imaging Evaluation of PAD �������(�������M��P$P

Recanalization Techniques of Iliac and Femoral Disease ���������\�M��P$P

RESILIENT: The Role of SFA Stenting O���!�5�V�M��P$PThe Role of Covered Stents in Treating the SFA ����������+�+��VM��P$PDrug Delivery for PAD: Which Agent and When? Q���(�����M��P$P\���;���_�����������+�*���� ���X����������=���� ���+����$�4�M��P$P

Drug-eluting Balloons: The Promise and Challenges Q���(�����M��P$P

Tibial Interventions ������������M��P$PP$"+##����� Lunch $+$������ Session III: Peripheral Arterial Disease (continued)

KEYNOTE LECTURE: The History of Innovation in Cardiovascular Care in Latin America

����������VM��P$P

Carotid Stenting: What Is the Role Today? ����������+�+��VM��P$PChallenging Carotid Stent Cases ����������VM��P$PMost Patients with Carotid Stenosis do Not Need Revascularization %������.����M��P$P

2:00 P.M. Session IV: Submission Case Presentations Case PresentationsDiscussion

3:00 p.m. Refreshment Break 3:30 p.m. Session V: Evolving Technologies

Emerging Technologies in Embolotherapy �������(�������M��P$P

Prostate Embolization: Is There a Future? �����������������M��P$PUpdate on UFE Embolization ������5�������4!M��P$PExtending Dialysis Access: The Role of PTA and Stents ������(�������M��P$PSaphenous Vein Incompetence: Diagnosis, Treatment and Setting Up a Successful Program

�������.��V���M��P$P

Central Vein Occlusions: Tools and Techniques �������(�������M��P$P

Marketing Strategies to Develop a Successful Clinical Practice in Latin America �������.��V���M��P$P

Venous Intervention for Multiple Sclerosis ���+����$�4�M��P$P

Renal Denervation: Why, When and How ������������M��P$P

5:00 p.m. Adjourn

Page 12: International Symposium on Endovascular Therapy (ISET)

���)����������!����������/����4�/�����!+���&����������5��Course Directors:�(���+�����$�<��M��P$P��������� �8��M��P$P

8:00 a.m. Session I: IntroductionPublic Health and Economic Impact of Stroke and How to Solve it .���+������M��P$P

Stroke Types and Etiologies ����������M��P$P

What Is Wrong with Mr. Jones?: Clinical Approach to a Patient with a Stroke ����������M��P$PStroke Prevention: Update on Medical Management of Asymptomatic Carotid Stenosis )+�������������M��P$P

$#+##����� Refreshment Break

$#+%#����� Session II: CEA Versus CAS: Choosing the Right Technique for Each Patient O���!�5�V�M��P$PCervical Dissections: Medical and Endovascular Management $������M��P$PNeuroimaging Perspective: Is Plain CT Good Enough? )�����Q���M��P$P

Advanced Neuroimaging in Acute Stroke %�<���&��M��P$P

Secondary Stroke Prevention: The Use of Antiplatlets and Anticoagulants .���+������M��P$PPanel Discussion: Should IVTPA Continue to Be the Standard of Care in Acute Stroke?

Panelists

$"+##����� Lunch $+##����� Session III:

Selecting the Right Patient for Endovascular Treatment %�<���&��M��P$PNeuroIR Stroke Armamentarium and Techniques (���+�����$�<��M��P$PUpdate on Clinical Trials of Endovascular Stroke Treatment .������������M��P$PAre Stentrievers the Final Solution? .������������M��P$P

Case Presentation and Panel Discussion.������������M��P$PM�(���+�����$�<��M��P$PM����%�<���&��M��P$P

2:30 p.m. Refreshment Break 3:00 p.m. Session IV:

Management of Symptomatic Intracranial Stenosis: What Is the Future? ������W����M��P$P

Endovascular Treatment of Vertebral Artery Origin Stenosis (���+�����$�<��M��P$P

Particularities of Acute Vertebrobasilar Occlusion )�����Q���M��P$P

Sinus Thrombosis: Update on Management ����� �8��M��P$P$

Case Presentation and Panel Discussion

(���������$�<��M��P$PM������ �8��M��P$PM��)�����Q���M��P$P�M�$������M��P$PM������$����!M��P$P��������4�'��4��M��P$P

Developing a Stroke Network $������M��P$P

Elements of a Stroke Center ������W����M��P$P

Managing In-Hospital Stroke Costs ���4�'��4��M��P$P

Question and Answer

5:30 p.m. Adjourn

Day 1: Saturday, January 19, 2013

Page 13: International Symposium on Endovascular Therapy (ISET)

���)����������!�����������/�6+�%�������������������������7������������/�%����������������8�������������)��+�������

�������$������/�Q���5��+M���M�.�

7:00 a.m Breakfast

Welcome and Introductions/Interactive Polling Q & A Q���5��+M���M�.�Healthcare Economics and Surviving the Challenges of Reform O���!�5�V�M��P$P

8:30 a.m. Session I: Transformational Transcatheter Therapies Transcatheter Aortic Valve Implantation: Why Is TAVR So Important? ��<���������M��P$P

Patient Selection for TAVR (�����(���M�%.��

TAVR Procedures in the Hybrid Environment .����[������M��P$P

Panel Q & A Panelists

9:45 a.m. Refreshment Break

$#+##����� Session II: The Great Debate: Atrial Fibrillation (A-Fib) Management

Etiology and Risk Factors ���!�5����4��M�.)�".#"�7#

Cryoablation Treatment Techniques �8����(�V���VM��P$PAtrial Appendage Closure: Lariat Suture Technique .����[������M�P$P

Surgical Treatment ��<���������M��P$P

Medical Treatment Q��+��.�<���M��P$P

Questions and Answer Panelists

$$+##����� PCI Update What’s New in PCI?: Appropriate Use Criteria Q��+��.�<���M��P$P

$$+%#����� Session III: Neurointervention Update Treatment of Cerebral Aneurysms: Coil Versus Stents for Optimal Outcomes .�<����)�������M�.)M�."�7#

New Treatment Alternatives (���+�����$�<��M��P$P

$"+##����� Lunch

$+##����� Session IV: New Interventional Treatments for Disease Management

Hypertension: Advances in Endovascular Therapies 5���+��.��+�;���+M��P$P

Multiple Sclerosis and the Venous System: Is there a Link? ���+����$�4�M��P$P

2:00 p.m. Session V: Peripheral Vascular Disease

Ischemic Limb Salvage %��@�������M��P$P

Diagnostic CT and MR Vascular Imaging Techniques���4���������M�.)�".#"�)#M�����������%����M�.)�".#"�.#

2:30 p.m. Refreshment Break 3:00 p.m. Session VI: Quality and Safety

Contrast-induced Acute Kidney Injury ����$�� �����VM��P$P

Risk Assessment and Reduction ���+����.�<<��M�.�M�O��

Blood Pooling Contrast Agents for MR Scans �������%�����.)�".#"�.#

Case Presentations $�����7�V]��VM�.�

Radiation Safety: New Research and Occupational Must Haves (������]��VM�.)�".#"�7#

Radiation Reduction Techniques for CT ���4���������M�.)�".#"�)#

Continuous Quality Improvement Through Accreditation ��������5�����M���$M�%.��

Questions and Answer

4:45 p.m. Adjourn

Page 14: International Symposium on Endovascular Therapy (ISET)

Day 2: Sunday, January 20, 2013���)����������!���������7/���;��������7��������$�������/����;�8;+�;%�7:00 a.m Breakfast 8:00 a.m. Session I: Symposium on Carotid Disease: Part I Moderator: Q������P�O����M��P$P Welcome and Introduction Q�����O����M��P$P

How I Interpret Internal Carotid Artery Stenoses with Duplex: Velocities, Waveforms, Plaque Evaluation

Q�+���������M��P$P

ICA Case Review and Polling Q�����O����M��P$P

First Step Towards Standardization: Results from a Survey Regarding Stenosis Criteria for Carotid Duplex

'��+���(����4M��P$PM�.7)

Commentary: Are Any Criteria Good Enough? ���!���������M��P$P

*�������\�����|���������+������������������ �� ������������*���� ����������of Plaque Be Mandated in the Report?

�+������O����4M��P$P

Questions and Commentary on Plaque Characterization '��+���(����4M��P$PM�.7) Tips to Improve Accuracy of Carotid Duplex Interpretation Q�+���������M��P$P Pitfalls in the Interpretation of Carotid Duplex Exams �+������O����4M��P$P Avoiding Pitfalls: Questions and Answers Q�����O����M��P$P Interactive Case Presentation: Challenging Carotid Duplex Cases '��+���(����4M��P$PM�.7)$#+$#����� Refreshment Break $#+�#����� Session II: Symposium on Carotid Disease: Part II Moderator:�Q�����O����M��P$P Non ICA Pathology on the Carotid Duplex Exam: You Better Look at Everything ��+������'���M�.7)M��OO�+M�.�7� CIMT: How to Do the Exam and What it Tells Us ������ �<��������M��+$ Counterpoint: This Test Is Not Yet Ready for Primetime Q��+���O��4��M��P$PP QA Panel on Carotid Duplex ���!���������M��P$P Panelists:�Q�+���������M��P$PM����+����Q�88M�$�M�'��+���(����4M��P$PM�.7)M��+������O����4M��P$PM��������� ����������������������������������Q�����O����M��P$P���������� �<��������M��+$

Live Case Scanning: How to Evaluate the ICA Before and After Treatment Moderator: Q�����O����M��P$P_�Scanner:���+������'���M�.7)M��OO�+M�.�7�

Panelists:�Q�+���������M��P$P_�'��+���(����4M��P$PM�.7)_��+������O����4M��P$P$"+##����� Lunch $+##����� Session III: Symposium on Arterial Disease Moderator: %��@�������M��P$P The ABI as a BioMarker for Global Cardiovascular Disease: It’s More than the Legs ���+����Q�88M�$� Consensus Panel on Screening: Carotids, Arterial Lower Extremity and AAA Moderator: ���+����Q�88M�$� Panelists:�������OP�O���M��P$PM���+������O����4M��P$PM�%+�!��������M��P$P����Q��+���O��4��M��P$P Physiologic Testing Versus Imaging: When to Order What in PAD Patients Q�����O����M��P$P Commentary: What About Functional Testing for Wound Healing and Limb Salvage? Q��+���O��4��M��P$P Duplex for AAA Evaluation and Endoleak Diagnosis: Is it Ready for Primetime? ������OP�O���M��P$P Commentary on Duplex for AAA �+������O����4M��P$P Interactive Challenging Cases in Mesenteric and Renal Duplex Exams ������OP�O���M��P$P2:35 p.m. Refreshment Break 3:05 p.m. Session IV: Symposium on Venous Disease Moderator: ���������\�M��P$P

Acute versus Chronic versus Recurrent DVT: How to Differentiate These with Duplex Evaluation

�+������O����4M��P$P

Controversial Topics in Venous Duplex Evaluation: Current ACCP Recommendations and Value of Bilateral Exams in Patients with Unilateral Symptoms

���!���������M��P$P

Commentary on Venous Controversies Moderator: %+�!��������M��P$P Panelists: ���!���������M��P$PM���+������O����4M��P$PM�������� �<��������M��+$ The Upper Extremity Venous Exam: How to Perform and Interpret the Exam ������ �<��������M��+$

Case Presentations: Interpreting Upper Extremity Venous Exams��+������'���M�.7)M�OO�+M�.�7�����������OP�O���M��P$P

'����������� �� ��;���^��^���+�<������<�����������4�������'��� � Q����%������M��P$P \�����������;���^�X��^��^���+������ ����\��������� ������ �<��������M��+$ Questions and Answers 5:00 p.m. Adjourn

Page 15: International Symposium on Endovascular Therapy (ISET)

���)����������!��������7/����������8�������������+���+�����'���+��������������������

9:30 a.m. Session I:Moderators: ���+����Q�88M�$P�P����O���!�5�V�M��P$P

Keynote Address: Economic Challenges Being Faced by Healthcare Systems ��P�O����5����! Affordable Healthcare Act: Understanding It and How it Will Affect Your Practice 5�+!�5���M��P$P

A Snapshot of the Future of Endovascular Therapies ��P�O��������

Integrating Healthcare Economic Analysis Into Clinical Research ��P�%������+��

Second Annual Vascular Masters Program: Integrating the Clinical and Economic Management of Vascular Procedures

���+����Q�88M�$P�P

$"+##����� Lunch

$+$������ ���������+�*����������=����������������������� ������*�������"#$%Moderators: %��@�������M��P$P�������+����Q�88M�$P�P

The Role of Physicians, if Any, in Coding and Reimbursement Policy 5�+!�5���M��P$P Compliance Risk and Management in Billing and Coding, Future Changes ��P�Q��� ��<���!

`����������X������������"#$% ��P�.��Q��4��

Q & A on Coding

"+$������ Session III: Hospitals and PhysiciansModerators:�O���!�5�V���P$P�������+����Q�88M�$P�P

Vascular Quality Initiatives: What Is Happening in Vascular Therapy and Will Quality Be Linked to Reimbursement?

Q��4�������M��P$P

Trends in Employment Models for Physician Groups Q��4�W�88��M��+$PM�P$P

Physician Hospital Alignment Models: The BCVI LLC O���!�5�V�M��P$P

Are Physician Employment Models the Only Option? A Hospital Adminstrator's Perspective

���������������

Physician-Physician Alignment Models: The RASF Solution Q�����O����M��P$P

3:30 p.m. Refreshment Break

4:00 p.m. Session IV:Moderators: O���!�5�V���P$P�������+����Q�88M�$P�P

���������������<��� !���������������� ����� �*�����������"#$%���+����Q�88M��P$PM���������.�������

The Changing Reimbursement Landscape in Massachusetts 5��+�.���^���M��P$P The Economics of Interventional Procedures in OutPatient Centers ?�������Q����M��P$P Cost of Device Selection for PAD Intervention: Does it Matter? ���4�O��4�M��P$P

Panel Discussion: Creating Solutions

5:00 p.m. Adjourn

Page 16: International Symposium on Endovascular Therapy (ISET)

���)����������!��������7�/�%���������7������������������<���+����!

7:00 a.m Breakfast 8:00 a.m. Session I: Moderators:

'�� �����|������������+�*������ ����������]��� ����� W���'��4��M��P$P

Work up of Patients with Vascular Malformations: Imaging, Testing and Medical Therapy ?�������.�����M��P$P High Flow Malformations: Approach and Technologies of Embolization .�<���.���M��P$PP Liquid Embolic Agents for High Flow Malformations W���'��4��M��P$P

ETOH for High Flow Malformations: Technical Considerations and When to Use this Agent

?�!��&�4��M��P$P

Craniofacial Malformations: Special Considerations (���+�����$�<��M��P$P Low Flow Vascular Malformations: Techniques and Agents ������5�������4!M��P$P Micro and Microcystic Lymphatic Malformations: Therapeutic Approach .�<���.���M��P$P9:45 a.m. Refreshment Break

$#+$������Comprehensive Multispecialty Management of Vascular Malformation: When to Operate, When to Embolize and When to Manage Medically

�+�������!M��P$P

Complications from Embolization of Vascular Malformations ?�!��&�4��M��P$P$#+������� Session II: Case Presentations with Discussions Moderators:

Case Presentation A .�<���.���M��P$P Case Presentation B (���+�����$�<��M��P$P Case Presentation C ?�������.�����M��P$P Case Presentation D ?�!��&�4��M��P$P Case Presentation E ������5�������4!M��P$P$$+%#����� Session III: Symposium on Venous Intervention Moderators:

Upper Extremity Venous Reconstruction for Chronic Venous Occlusive Disease ��+����+���^M��P$P New Techniques for Recanalization .�+�������M��P$P$"+##����� Lunch IVC Filters: US Trends, What the FDA Wants and What You Should Know ��+���Q�+��M��P$P

Retrievable IVC Filters: Expanding Indications, Retrievable Rates and Other Contemporary Issues

%�.�<���M��P$P

New Filter Technologies: What's Coming in the Future Q�+�5��8��M��P$P

Treatment Strategies for Acute Lower Extremity DVT: Chemical versus Mechanical Recanalization

Q�8���(��V����M��P$P

Fundamentals of DVT Medical Management Q�88���!����M��P$P Post Phlebotic Syndrome: Best Medical Management %+�!��������M��P$P Chronic Lower Extremity Venous Reconstruction: Techniques and Outcome %��@�������M��P$P

2:45 p.m. Refreshment Break

%+$������ Session IV: Moderators:

Surgical Options for Chronic Venous Occlusive Disease in the Lower Extremities %+�!��������M��P$P

Venous Stenting for May-Thurner Syndrome: After Thrombolysis and In Veins that Have Not Yet Occluded

%�.�<���M��P$P

Varicocele Embolization: Techniques and Outcomes ����!����+�M��P$P

Pelvic Congestion as an Etiology for Lower Extremity Varicose Veins: Diagnosis and Management

Q�+�.��<��4M��P$P

CCSVI: Is it Real and What do We Know? ���+����$�4�M��P$P

Techniques and Outcomes of Venous Interventions for CCSVI (��!����4�M��P$P

5:00 p.m. Adjourn

Day 2: Sunday, January 20, 2013

Page 17: International Symposium on Endovascular Therapy (ISET)

���)����������!��������7��/������������8�7��������$�����������)+����!/�����������8����������%$�$������������������

7:55 a.m. Session IModerators:��.�����(��+�M��P$P����%����(�������M��P$P

Welcome and Introduction O���!�5�V�M��P$P

The Scope of PAD and Its Link to Cardiovascular Risk O���!�5�V�M��P$P

Lipid, Hypertension and Antiplatelet Management ���+����Q�88M�$�

Medical Management of Claudication Q��+�O��4��M��P$P How to do a Vascular Physical Exam: Live Demonstration ���+����Q�88M�$�

Role of the Vascular Lab in the Diagnosis of Peripheral Vascular Disease Q�����O����M��P$P

Differential Diagnosis of Lower Extremity Ulcers ���+����Q�88M�$� Clinical Evaluation of the Patient with Acute Limb Ischemia %��@�������M��P$P Clinical Evaluation of the Patient with Critical Limb Ischemia Q�88��!����M��P$P

Case-Based Techniques: Aortoiliac Disease .�+�������M��P$P

Case-Based Techniques: Femoropopliteal Disease (��!�%���M��P$P

$#+##����� Refreshment Break

$#+%#����� Session IIModerators:���F�!������M��P$P�����+����������M��P$P

Case-Based Techniques: Infrapopliteal Disease O���?���+��M��P$P

Post Vascular Intervention Medical Management ��������$��+�M�P$P

Evaluation of the Patient with Carotid Disease: Who Gets Treated and How? %+�!��������M��P$P

Technical Principles of Carotid Stenting P�������`���4`�'��4��M��P$P

Brachiocephalic and Subclavian Disease: Patient Selection and Management ���������\�M��P$P Interactive Case-Based Discussion: Carotid, Brachiocephalic and Subclavian Disease (���+�����$�<��M��P$P$"+##����� Lunch

$+$#����� Session IIIModerators:�����������\�M��P$P�����+����������M��P$P

Abdominal Aortic Aneurysm (AAA): Patient Evaluation and Management (������7��4��+���!M��P$P

EVAR for AAA: From Device Selection to Step-by-Step Technique %����������M��P$P

AAA: Advanced Endovascular Options in the Nonsurgical Candidate �+����������M��P$P

Aortic Dissection: What a Clinician Needs to Know ���+����$�4�M��P$P

Thoracic Aneurysms: Evaluation and Treatment ���4�������M��P$P

Noninvasive Assessment of Patients with Renal and Mesenteric Vascular Disease ���������\�M��P$P

Renovascular Disease from Start to Finish %����������M��P$P

Acute and Chronic Mesenteric Ischemia: The Complete Workup from Initial Patient Encounter to Treatment

%����(�������M��P$P

Renal and Visceral Aneurysms: Patient Evaluation and Treatment .�����(��+�M��P$P Interactive Case-Based Discussion: Renal and Visceral Disease Q�+�.��<��4M��P$P3:00 p.m. Refreshment Break

3:30 p.m. Session IVModerators: .�����(��+�M��P$P����%����(�������M��P$P

Clinical Evaluation of the Patient with Venous Occlusive Disease %+�!��������M��P$P Acute DVT: Anticoagulation versus Endovascular Intervention W���'��4��M��P$P '����������� �� �+��*���� ��������������������������`������ Q����%������M��P$P IVC Filters: Current Issues and Complications %��.�<���M��P$P Evaluation and Endovascular Management of Pulmonary Embolism ��F�!������M��P$P Compression Syndromes: From the Thoracic Outlet to the Iliac Vein %+�!��������M��P$P How to Use Coumadin and Newer Antithrombotic Agents Post-intervention Q��+���O��4��M��P$P Case Based Techniques: DVT and Venous Compression Syndromes ?�������.�����M��P$P5:00 p.m. Adjourn

Page 18: International Symposium on Endovascular Therapy (ISET)

Day 3: Monday, January 21, 20137:30 a.m Breakfast, Visit Exhibits and Industry Sessions

'�?���$���/�6/ff��P�P�;�6/>f��P�P

7:00 a.m. How I Do It: Renal Intervention Case Presentation: %����������M��P$P Case Presentation: (��!�%���M��P$.7:00 a.m. How I Do It: Dialysis Access Intervention Case Presentation:�O���$�����+M��.$P Case Presentation:�W���'��4��M��P$P7:00 a.m. How I Do It: Large Vessel Closure Case Presentation:�W�������5��F���M��P$P Case Presentation: $�������M��P$P(���.% ��������

Overview of ISET 25 O���!�5�V�M��P$P

7:55 a.m.Session I: Townhall: Sympathetic Denervartion -- The Next Great Endovascular Breatkthrough?

Moderators/�O���!�5�V�M��P$P�������!� ��M��P$P

Welcome ��P�O����5����!The Role of Sympathic Nervous System in Cardiovascular Function Q�+���<��M��P$P

Sympathetic Denervation: History and Current Methods Overview $�����5��V���M��P$P

Renal Denervation for HTN European Experience ������������M��P$P

Renal Denervation: Potential Role in Diabetes? ���+����Q�88M�$�

Renal Denervation: Role in Sleep Apnea and Other Applicaitions? 5���+��.��+�;���+M��P$P

Panel Discussion �������/

ISET Career Achievement Award: (��!�QP�O��4��M��P$P Presenter: O���!�5�V�M��P$P

Live Case DemonstrationsOperators:�O���!�5�V�M��P$PM����!� ��M��P$P

$#+%#����� Refreshment Break and Visit Exhibits

$$+##����� Session II: Summit on RestenosisModerators:�O���!�5�V�M��P$P�������!� ��M��P$P

The Frustrations of Restenosis ������������/�.�<���������M��P$PUnderstanding Restenosis: From Bench to Clinic ��F�!������M��P$PSurface Characteristics and Restenosis Q����������VM��P$PPharmacologic Control of Restenosis: What Are the Options? Q���(�����M��P$PClinical Evidence Supporting Drug Delivery ���!� ��M��P$P<���� ����|�� ���������+�� �������=����Z (��������M��P$P

����������������������\����;�� ������+�*���`�������� ����������� �X���������*�������6�X���6�\�������Z Panelists:�.�<���������M��P$PM���F�!������M��P$PM�Q����������VM��P$PM��Q���(�����M��P$PM�� � � � � � � � � � ������!� ��M��P$P���M�(��������M��P$P$"+$������ Lunch, Visit Exhibits and Industry Sessions

$+"������ Session III: Carotid and Stroke PreventionModerators:�O���!�5�V�M��P$P����?�������(��!M��P$P

*X���6�<*��$�����`����������+���������������������*�������������� Today? ?�������(��!M��P$PLive Case Demonstrations

3:00 p.m. Refreshment Break and Visit Exhibits

3:30 p.m. Session IV: Critical Limb IschemiaModerators:����������\�M��P$P�������4�7��+M��P$P

Managing the Diabetic Foot: When to Intervene Q��+���O��4��M��P$POverview of Crossing Devices: What Are They and When Are They Useful? Q�+�.��<��4M��P$PTibial Intervention: State of the Art .�<��� ��4���M��P$PPedal Access for Tibial Intervention: When and How? .�<����(����M��P$PStents for BTK Intervention: BMS Versus DES -- When to Use What? $���4���+����M��P$PEvolution of Limb Salvage Techniques and Where They Are Going ���4�7��+M��P$P

4:30 p.m. Adjourn for Concurrents

Page 19: International Symposium on Endovascular Therapy (ISET)

����H..��)���������

4:30 p.m. Concurrent Session I: Carotid Stenting TodayModerators: ����������\�M��P$P����?�������(��!M��P$P

Proximal Occlusion for Cerebral Protection .�<���O����M��P$P

�����X�����+�� ����������=���� ����������+�+��VM��P$P

Overview and Rationale of Filters for Embolic Protection Q�+�.��<��4M��P$P

Making Carotid Stenting Safer: Fundamentals of Good Technique and Outcomes ?�������(��!M��P$P

Complications of CAS and their Management 5�������+���M��P$P

*��������������������+�����=����Z P�������g���4g�'��4��M��P$P

Brachiocephalic and Vertebral Stenting (���+�����$�<��M��P$P

Hybrid Procedures for Brachiocephalic Lesions O���!�5�V�M��P$P

Carotid Stenting Today and Tomorrow ?�������(��!M��P$P

4:30 p.m. Concurrent Session II: Abstracts and Late-Breaking TrialsModerators:�Q������P�O����M��P$P����������.����M��P$P

To Be Announced

4:30 p.m. Concurrent Session III: Hot Topics in Interventional CardiologyModerators:�.����[������M��P$PM��������!� ��M��P$P

Practical Tips and Tricks for TAVR with the Sapien Valve ���!� ��M��P$P

Practical Tips and Tricks with the COREVALVE Device �<��+����(��<�M��P$P

The Sadra Lotus Valve for TAVR )���������M��P$P

Valve in Valve Procedures .��?�4���M��P$P

Basics of Trans-septal Puncture )���������M��P$P

Atrial Appendage Closure: What Will it Take to Make it First Line Therapy? .����[������M��P$P

Update on Mitral Valve Procedures (��������M��P$P

Current Indications and Techniques of Mitral Valve Repair )���������M��P$P

TEAM Bulding for Major Procedures .��?�4���M��P$P

Page 20: International Symposium on Endovascular Therapy (ISET)

7:30 a.m. Breakfast, Visit Exhibits and Industry Sessions

'�?���$���/�6/ff��P�P�;�6/>f��P�

7:00 a.m. How I Do It: Challenging Endoleaks Case Presentation: ����������+�+��VM��P$P Case Presentation: Q�+���� �����M��P$P7:00 a.m. How I Do It: Central Venous Occlusions Case Presentation: �������(�������M��P$P Case Presentation: W���'��4��M��P$P7:00 a.m. How I Do It: Pedal and Radial Access Case Presentation: Q�+�.��<��4M��P$P Case Presentation: .����[������M��P$P

(���.% ��������

8:00 a.m. Session I: Next-generation Devices for EVARModerators:�O���!�5�V�M��P$PM�������4�7��+M��P$P

Update on the OVATION Trial ���+����$�4�M��P$P

Update on the INSPIRATION Trial .�<���O����M��P$P

Update on the NELLIX Trial O���!�5�V�M��P$P

Update on the Fenestrated Device (������������+M��P$P

Update on the PYTHAGORUS Trial on Angulated Necks ?�������(��!M��P$P

Update on the VENTANA Trial $����������M��P$P

Live Case Demonstrations$#+%#����� Refreshment Break and Visit Exhibits

$$+##����� Session II: Managing Unfavorable EVAR AnatomyModerators:�Q�+���� �����M��P$P�����+����������M��P$P

The Short Proximal Neck: Should These Be Done with EVAR and How? $�����O���4���M��P$PChimneys and Snorkels: Rationale and Techiques ����������+�+��VM��P$PA Prospective Trial Comparing Hypogastric Embolization Versus Revascularization with the "Sandwich Technique"

����������+�+��VM��P$P

DEBATE: Chimneys Are Better than Fenestration for Short Necks: PRO %��������������+�M��P$PDEBATE: Chimneys Are Better than Fenestration for Short Necks: CON $�����O���4���M��P$PRenal Stenting During EVAR: When and How to Do It .�<��� ��4���M��P$PManaging Tortuosity and the Angulated Neck with Good Results Q�+���� �����M��P$PWhat Is the FDA Doing to Accelerate Innovation in the United States? Speaker:�$���+!�%<��M�O�O��

$"+$������ Lunch, Visit Exhibits and Industry Sessions

$+%#����� Live Case Demonstrations3:00 p.m. Refreshment Break and Visit Exhibits

3:30 p.m. Session III: The Thoracic AortaModerators:����+����$�4�M��P$P����Q�����O����M��P$P

Update on TAVR ���!� ��M��P$PTrans-apical Access for Treating the Ascending Aorta O���!�5�V�M��P$PCurrent Standards for Treating Dissecting Aneurysms ���+����$�4�M��P$PNext-generation Devices for TEVAR ���+����$�4�M��P$PThe Brazilian Technique for Complex Thoraco-abdominal Aneurysms %������ �<��M��P$PState of the Art for Thoraco-abdominal Endo Solutions $����������M��P$P

4:30 p.m. Adjourn for Concurrents

DAY 4: TUESDAY, JANUARY 22, 2013

Page 21: International Symposium on Endovascular Therapy (ISET)

����H..��)���������

4:30 p.m. Concurrent Session I: Clearing up the Confusion on Drug Elution, Stents and BalloonsModerators: Q���(�����M��P$PM����������\�M��P$P

What Agents Are Effective for Inhibition of Restenosis? Q���(�����M��P$P<��� ���������;*=+�����;�������<X������ )+�����W�����M��P$PBiodegradable Stents: A Promising Future? .�<���������M��P$PDCB and BMS, versus DES and Bare Balloon? What Makes Sense? (��!�%���M��P$PA Unique and Simple Method of Drug Delivery for PAD .�<����(����M��P$P

What Is the Impact of DCB in Europe? ��������$��+�M��P$P

DCB: What Is the Longer Term Data Showing? (����)���M��P$P

Is There a Value for Drug Elution Below the Knee? .�<��� ��4���M��P$P

Biodegradable, Drug Eluting Scaffolds in Iliac Femoral Applications: Results of the ESPIRIT Trial

Q�+���� �����M��P$PP

Concurrent Session II: Technical Challenges in EVAR and TEVARModerators:��+����������M��P$P����%����������������M��P$P

Management of Endoleaks: What Are the Options? ����������+�+��VM��P$PRecurrent Endoleaks: Why and How Should They Be Managed, What Are the Success Rates?

(��V��P�.��+��M��P$PM��+$

Complications of EVAR: Recognition and Management Q��4�������M��P$P

Large Vessel Closure: How I do It W�������5���F��M��P$P

The PEVAR Trial: Update on Results W�������5���F��M��P$P

The 'Sandwich Technique' for Thoraco-abdominal Aneurysms %�������P� �<��M��P$PRenal Chimneys: Technique and Pitfalls ����������+�+��VM��P$PChallenges in Fenestrated Endografts (�������������+M��P$PPanel Discussion

4:30 p.m. Concurrent Session III: Renal and Visceral InterventionsModerators:�%����(�������M��P$P����%����������M��P$P

Fibromuscular Dysplasia: What do We Know Today? Q�88��!����M��P$P

Contemporary Approach to PTRA and Stenting )���+!�����+!M��P$P

Complications of Renal Stenting: Recognition and Management %����������M��P$PApproaches to Renal and Visceral Aneurysms Q�����O����M��P$PMesenteric Ischemic Syndromes: Endovascular versus Surgical Solutions .�<��� ��4���M��P$PCurrent Role for Covered Stents in the Renal and Visceral Arteries (��!�%���M��P$PIs There a Role for Embolic Protection in PTRA and Stenting? Q�+�.��<��4M��P$PRenal Denervation in Depth: Tips, Tricks and Challenges ������������M��P$PResistive Hypertension: Patient Care Assessment and Management ������������M��P$P

Page 22: International Symposium on Endovascular Therapy (ISET)

Day 5: Wednesday, January 23, 20137:00 a.m Breakfast, Visit Exhibits and Industry Sessions

'�?���$���/�6/ff����;�6/>f��P�7:00 a.m. How I Do It: Total SFA Occlusions Case Presentation: O���?���+��M��P$P Case Presentation: .��+������@�M��P$P7:00 a.m. How I Do It: DVT Management Case Presentation: (������7��4��+���!M��P$P Case Presentation: ��������$��+�M��P$P7:00 a.m. How I Do It: Iliac Aneurysm Management Case Presentation: (��V��P�.��+��M��P$P Case Presentation: %����������M��P$P(���.% ��������

8:00 a.m. Session I: Drug Elution for PAD: Is It Ready for Prime Time?Moderators: O���!�5�V�M��P$P����%+�!��������M��P$P

Framing the Problem: Long Segment SFA Therapy Stents Case Presenter: (��!�%���M��P$P

Framing the Problem: Long Segment SFA Therapy Covered Stents Case Presenter: .��+������@�M��P$.

Drug Delivery for Infrainguinal Disease: Which Agents Might Work and How do We Translate Work from the Lab to Our Patients?

Q���(�����M��P$P

Drug Eluting Stents for SFA Disease: Update on Current Results and How Should it Be Used in Daily Practice

���+����$�4�M��P$P

Best Results with BMS for SFA: What Are the Expectations? .�<���������M��P$P

Update on Drug Eluting Balloons (����)���M��P$P

Charles J. Tegtmeyer, M.D. Annual Lecture: Contemporary Concepts in the Management of Acute Iliofemoral DVT and Chronic Post-Thrombotic Iliofemoral Venous Obstruction

%+�!��������M��P$P

ISET LINC Trans-Atlantic Live Case & Lecture Session: Popliteal Artery and below the Knee Therapies Live Case From Leipzig: Complex Pobliteal and Below the knee Therapies

Live Case from BCVI: Management of Pobliteal Aneurysm O���!�5�V�M��P$PM��

Featured Research� � � � � � � � � � ������ � � � � � � � � � � � � � � � � � � � � � � � � ���$���4����+����M��P$P$#+%#����� Refreshment Break and Visit Exhibits

$$+##����� Session II: Challenges of Critical Limb Ischemia Moderators:

Case Presentation: SFA Occlusions: How to Recanalize Q�+�.��<��4M��P$P*��������;�� �+������<�����`�������������� � �Z (��!�%���M��P$PAorto-Iliac Recanalization: Techniques and Devices Q�8���(��V����M��P$PLong Segment SFA Therapy: Final Results of the VIASTAR Trial Q�+���� �����M��P$P

Long Segment SFA Therapy: What Is the Data? .��+������@�M��P$P

Can Drug Eluting Stents Improve Long-Term Patency? ��<��V���������M��P$P

Endovascular Management of Failed Bypass Grafts ��������$��+�M��P$P

$"+$������ Lunch, Visit Exhibits and Industry Sessions

$+%#����� Live Case Demonstrations

3:00 p.m. Refreshment Break and Visit Exhibits

3:30 p.m. Session III: Advanced Below the Knee Interventions Moderators:

Case Presentation: Tibial Occlusion: Technical Alternatives .�<��� ��4���M��P$PWhy Coronary Drug Eluting Stents Should Not Be Used in the Tibial Arteries ��������$��+�M��P$P

Tibial Intervention: When Should Stents Be Used? .�<��� ��4���M��P$P

Extreme Tibial Intervention: What Can Be Accomplished to Achieve Limb Salvage .�<����(����M��P$PPedal Access: Is it a Necessary Skill and What Can Be Accomplished? Q�+�.��<��4M��P$PClosure Devices: Overview and Application W�������5��F�����P$P

4:30 p.m. Adjourn for Concurrents

Page 23: International Symposium on Endovascular Therapy (ISET)

����H..��)�

4:30 p.m. Concurrent Session I: Stroke TherapyModerators:������ �8��M��P$PPM�(���+�����$�<��M��P$P����5�������+���M��P$P

What Imaging Must Be Immediately Necessary to Have a Successful Stroke Program? 5����%<����M��P$P

Case Presentation: Saving Time, Saving Brain ����� �8��M��P$P

What Technologies Are Available and Best for Acute Stroke Therapy Today? (���+�����$�<��M��P$PComplications of Stroke Therapy: What Should Be Our Expected Outcomes? 5�������+���M��P$PSpreading the Gospel: Should Stroke Training Be Multidisciplinary? P�������`���4`�'��4��M��P$P

Developing a Multi-hospital Regional Network ����� �8��M��P$P

Managing the Costs of a Stroke Program to Make it Successful ���+����.!���M��P$P

Case Presentations and Discussion

4:30 p.m. Concurrent Session II: Total Occlusions (CTO) in DepthModerators: .����[������M��P$P����Q�8���(��V����M��P$P

|����������<�������^������*�� �� ����� .�<����(����M��P$P

Long Segment SFA Occlusions: Subintimal versus Intraluminal Techniques -- does it Make a Difference?

Q�+�.��<��4M��P$P

Aortoiliac Occlusions: Recanalization Techniques Q�8���(��V����M��P$P

Technical Aspects of Coronary CTOs .����[������M��P$P

SMA Recanalization: Tips and Tricks Q�8���(��V����M��P$P

Coronary CTO: When to Start and When to Quit ���+���������!M��P$P

Complex Popliteal and Tibial Occlusions O���?���+��M��P$P

Pedal Access for Total Occlusions Q�+�.��<��4M��P$P

Re-entry Devices: When Can they Help? (��!�%���M��P$P

4:30 p.m. Concurrent Session III: DVT, Pulmonary Embolism and IVC FiltersModerators:�%��@�������M��P$PM�%��.�<���M��P$P

Endovascular Techniques of Lysis for DVT %+�!��������M��P$P

Filter or No Filter for DVT Lysis? ��+����+���^M��P$P

IVC Filters: Option or Permanent? %��.�<���M��P$P

Venous Stenting ��+����+���^M��P$P

Complications of IVC Filter Implantation %��.�<���M��P$P

Thoracic Outlet Syndrome: What Is the Role of Lysis? Surgery? Stenting? %+�!��������M��P$PPulmonary Artery Lysis: An Underutilized Procedure? ��������$��+�M��P$P

Managing Central Vein Occlusions W���'��4��M��P$P

A New Recanalization Technique for Occluded Central Veins �������(�������M��P$P

}+##����� ISET Adjourns

Page 24: International Symposium on Endovascular Therapy (ISET)

EXHIBITS

REGISTRATION

�j'�O�)��#�^��������������������������������������������������������������������"#$%������ More exhibitors than last year����Interactive learning stations� 25th Anniversary Welcome Reception: 7 to 9 p.m. Sunday, January 20�����^����������+�~+%#��������+%#������|�����6����������������������������"$_"%�

.�(��).%)���The International Symposium on Endovascular Therapy Registration Fee Includes:[��<������������� ����� ��������[��*������������������� �����������������������[��< ����������^���������[��<����������������� ���X �����[��;����� ������������!����6������������!�������^����� ���������^���������[��<����������������������� ���������������������� ��������

��������!�?�!����.������/� Online: www.ISET.org ���=����^+�%#�_"~�_�""$� By E-mail: [email protected]���=��\���+�4����*���������_%%�_~��������������������%#�_"~�_""}%��=��|���+�*������*����� �|�������6�$$��#�]��������;��6������%#}6�|����6��j�%%$~}���� � !���������

Questions?��������������������������������������6������ ���� ��*������*����� �|��������������_%%�_~�������%#�_"~�_""}%6����e-mail [email protected].

ALN IMPLANTS CHIRURGLAUX

Argon Medical Devices, Inc.

Arstasis, Inc.

Bard Peripheral Vascular

Baylis Medical Company, Inc.

Biocompatibles

Bolton Medical

=������� �����

Cardiovascular Systems, Inc.

Cook Medical

Dornier MedTech America, Inc.

EKOS Corporation

Endologix Inc

Endovascular Today

Gore & Associates

HMP Communications

Merit Medical, Inc.

Mckesson Revenue Management Solutions

Terumo Interventional Systems

TriVascular, Inc.

?%�)�)���j'�O�)�%)����)k����)%�)/�CLAUDIA DIAZ-GONZALEZ ��$H�).&��%.5�)��(��%�%(�.%#�_~""_��$#[email protected]

THE EVER-GROWING LIST OF EXHIBITORS INCLUDES:

Page 25: International Symposium on Endovascular Therapy (ISET)

CONTACT INFORMATION (Pre-registration closes January 13, at 11:59 PM EST. Registration will re-open on-site.)

First Name: Last Name:

� MD � DO � PhD � PA � NP � RN � BSN � RT � RT(R) � RT(R)(CV) � RVT � CVT � RCS � RDCS � RCIS � RDMS � None � Other: Home Address: City: State: Zip/Postal: Country: Medical Center/Hospital/Company: Daytime Phone: Mobile Phone: Fax: �_������X���������� ������������� ���� ���������������+ Pursuant to the Americans with Disabilities Act, please specify any special services you require: Do you require a letter of invitation for Visa purposes? � Yes � NoState(s) of Professional Licensure: License Number:

.�(��).%)��������On-site registrations will incur an additional $120 fee.

���O�/�����L����)������6����������$��@��������6���������"%�

���)���������6���������$��@��������6���������"%

���)����H��$��&�����%��������6���������$��@�������6���������"#�

� ����% ���)�.7��)���% ����� �(&�"���#������6���������$��@���������6���������$��

������!����)����������!������/� 7th Annual Innovations in Cardiac and Vascular Care: Advanced Interventions for Nurses and Technologist� ISET Meets the Americas� Stroke: Everything You Need to Know about the Diagnosis and Management of Stroke

����!����)����������!������/� Symposium on Noninvasive Vascular Diagnosis� Strategies for Success in the Changing Healthcare Economic Environment� Venous Interventions and Embolotherapy� Fundamentals of Vascular Diagnosis and Therapy

PHYSICIAN ALLIED HEALTH PROFESSIONAL INDUSTRY/NON-CLINICAL

� Interventional Radiology�Vascular Surgery� Interventional Cardiology� Clinical Cardiology� Clinical Radiology� Internal Medicine� Neurology� Vascular Medicine� Cardiothoracic Surgery� Oncology� Other:_____________________

� Physician Assistant� Registered Nurse� Nurse Practitioner� Cardiovascular Technologist� Radiologic Technologist� Registered Radiologic Technologist��X�������*�������� �����*������X�������� �� ���������� Registered Diagnostic Medical Sonographer� Registered Diagnostic Cardiac Sonographer� Registered Vascular Technologist� Registered Cardiovascular Invasive Specialist��*������*���� ���X��� ��<��� �����*������*���� ���X��� ��*����������� Student � Other:___________________

� Industry Professional� Scientist� Engineer� Biomedical Engineer� Other:__________________

���$�������������� $900 � $900 ���$���

���$%���������������}##� � ����}##�� �����$%��

� $549 � $249 � $249 � $549

���}�#������������� $300 � $300 ���}�#

PhysicianFellow,

ResidentAllied Health Professional

Industry, Non-Clinical

REGISTRATION

�����% )&K.�(��).%)����)&�� (Please select only one)

(As continuing education providers, it is important to our recordkeeping process to maintain information relating to our learners’ licensure. To that end, providing your professional license number is optional, but of importance to continuing education efforts.)

Page 26: International Symposium on Endovascular Therapy (ISET)

.�(��).%)����"������#SPOUSE REGISTRATIONSpouse registration, accompanied by a registered attendee, is $200 for the duration of the symposium. This includes access to all educational sessions, opening reception, continental breakfast, lunch, and breaks. Please note that the fee does not include meeting materials or ���� ������������� �� Spouse Registration - $200First Name: Last Name: E-mail: ����.)%�)�����.�%)���[��*�`+������ ������������!���� �������6���������$�6�<];���������6���������$����������������������������������*�`6������������������������ attendance will be Sunday, January 20.[��*������������X�����+�<����������������������������������������������� �������������������������������������� �����������\������^�������������%#�_"~�_�""$������������������������ � �� ���[��|��������\���� �����<�������������������4������������������������������������������������������� �����\������^������������%#�_"~�_�""$������������������������ � �� ����

$���(.%�'�������.�%)���Which of these contributed to your decision to register for the upcoming meeting?

� Email/Electronic Newsletter� I am a Past Attendee� ISET Exhibit Booth at Other Meetings Meeting: ______________________� Mailed Brochure� Journal Advertisement� Colleague/Institution� Facebook� LinkedIn� Fax Blast� Industry Representative� Online Advertisement� Twitter� Online Calendar� Other ______________________

�%&���)�����.�%)���The option to make hotel reservations at the discounted rate will be available online once registration has been completed and paid in full. Please note that your registration will not be complete, and housing will not be available, until your payment is received.

� Visa � MasterCard � American Express � Check (Payable to: Complete Conference Management)

Card Number: Expiration Date: Security Code:

Name as it appears on card:

Billing Address:

Authorized Signature: Date: Total:

�%��� %)������ ��&/�*�� ���������������� �������������������������; ���"�6�"#$"6�������������������$�#�������������������X������� ���������; ���"�6�"#$"6������������������ ��������!�?�!����.������/� Online: www.ISET.org ���=����^+�%#�_"~�_�""$� By E-mail: [email protected]���=��\���+�4����*���������_%%�_~��������������������%#�_"~�_""}%��=��|���+�*������*����� �|�������6�$$��#�]��������;��6������%#}6�|����6��j�%%$~}���� � !���������

This educational activity provides training necessary for licensed attendees to maintain state licensing requirements. The tuition for this educational activity is subsidized in part by unrestricted educational grants, including for those attendees who have successfully completed the ������� ���������������������������� ���������������������������� ���������������������������������� �������

%���(����

� Under 30� 30-40���$_�#���$_}#��}$��������

�����������If you received a mailed postcard or brochure, please provide the 3 or 4 letter code found above your name on the address label:

REGISTRATION

Page 27: International Symposium on Endovascular Therapy (ISET)

Hotel Options (Hotel rooms are limited, please reserve early to ensure preferred accommodations.) )+�������<�����������O���+�'���m����$�*�������<�6�|�����=� �6��j�%%$�#Special Meeting Rate: $329 (Standard Room)X����=��; ��"$6�"#$"� �X����%"�6��������^

Fontainebleau Miami Beach is a spectacular blend of Miami’s glamorous golden era and stylish modern luxury. A landmark ��� ������������$���6������������|�����=� ��������restored and transformed by a team of renowned architects and designers to create the most dynamic destination resort on the ���������������������������� ����$�����������������6����22-acre Fontainebleau Miami Beach now features signature ������������������_������� ��������� �� ������������������two-story, 40,000-square-foot spa, an expansive poolscape, a pristine Atlantic Ocean beach and state-of-the art conference and event facilities.

����������O!��+�����������O���+���%�%�*�������<���6�|�����=� �6���������%%$�#Rates start at $209 (Standard Room)X����=��; ��"$6�"#$"� �X����"#�6��������^

The Four Points by Sheraton Miami Beach, located just one block south of the Fontainebleau, represents Modern History! Recently renovated, the Four Points has kept the historic charm and Miami Modern exterior while stylishly updating interiors for guest comfort. This property, located on the oceanfront, features "$}����������������������������������6������������ �restaurant and room service, outdoor oceanside pool area, a tiki bar and more.¡X��������������������������������������������"#$%��������������� �����������������=�����

ACCOMMODATIONS

O��4���(���������The deadline to reserve rooms at the discounted group rate for the Fontainebleau Miami Beach or the Four Points Sheraton |�����=� �����; ���"$6�"#$"6������������������������� �����������������������6���� ���� ���������Reservations at the group rate will not be accepted by contacting the hotels directly. In order to receive special group rates, rooms must be booked online through the ISET Housing Bureau after registration has been completed and paid in full for ISET "#$%��<����!�������������������� ����������������������� ����������������All reservations must be made through the ISET Housing Bureau. Hotel reservation instructions will be e-mailed to you after ����������"#$%���������������� �������

Booking reservations through the ISET Housing Bureau acknowledges your understanding and agreement of the guidelines set forth above.

Page 28: International Symposium on Endovascular Therapy (ISET)

Q%�H%.&�pq;=�M�=fp�

FIRST CLASSPRE-SORT

U.S. POSTAGEPAID

PERMIT #2464MIAMI, FLORIDA

��$�.���(��.(%��W%)����ISET is proud to join forces with these leading international organizations to promote endovascular medical education.

RADIO

LOG

IAV

AS

COLARE ED INTER

VE

NT

ISTICA

��.�Italy

ISET is proud to promote the P.A.D. Coalition